thromboplastin and lipoteichoic-acid

thromboplastin has been researched along with lipoteichoic-acid* in 3 studies

Other Studies

3 other study(ies) available for thromboplastin and lipoteichoic-acid

ArticleYear
Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide.
    Critical care medicine, 2009, Volume: 37, Issue:2

    Pneumonia is characterized by an acute inflammatory response in the lung, which is frequently associated with changes in coagulation and fibrinolysis in the bronchoalveolar space. Here, we compared the effects of lipoteichoic acid (LTA), a major cell wall component of Gram-positive bacteria, and lipopolysaccharide (LPS), in the human bronchoalveolar space.. Controlled in vivo volunteer study.. Clinical research unit.. Twenty-three healthy nonsmoking male volunteers.. Sterile saline was instilled into a lung subsegment followed by bronchoscopic instillation of either LTA (Staphylococcus aureus, at a dose of 4, 20, or 100 ng/kg body weight) or LPS (Escherichia coli, 4 ng/kg body weight) into the contralateral lung. Bronchoalveolar lavage fluid was obtained 6 hours thereafter.. Bronchial instillation of LTA- or LPS-activated bronchoalveolar coagulation, as reflected by increases in the levels of thrombin-antithrombin complexes, d-dimer, and soluble tissue factor. Concurrently, LTA and LPS inhibited anticoagulant mechanisms, as indicated by reductions in antithrombin, Protein C, and Activated Protein C concentrations together with elevated levels of soluble thrombomodulin. Both LTA and LPS administration was associated with an inhibition of pulmonary fibrinolysis, as measured by a reduction in plasminogen activator activity and elevated levels of plasminogen activator inhibitor type I.. This study is the first to describe the effects of LTA on hemostasis in humans, demonstrating that LTA induces similar changes in the human bronchoalveolar space as LPS, characterized by activation of coagulation with concurrent inhibition of anticoagulant and fibrinolytic pathways.

    Topics: Blood Coagulation; Bronchi; Bronchoalveolar Lavage Fluid; Dose-Response Relationship, Drug; Fibrinolysis; Hemostasis; Humans; Lipopolysaccharides; Lung; Male; Teichoic Acids; Thromboplastin; Young Adult

2009
Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.
    FEMS immunology and medical microbiology, 2008, Volume: 52, Issue:1

    Staphylococcus aureus is one of the most significant pathogens in human sepsis and endocarditis. A hallmark of these endovascular S. aureus infections is that the coagulation system is triggered by a tissue factor (TF)-dependent pathway. This study demonstrates that highly purified S. aureus peptidoglycan, lipoteichoic acid (LTA) and TSST-1 increase TF mRNA and TF surface protein in human umbilical vein endothelial cells (ECs). Concomitantly, peptidoglycan- and LTA-activated ECs express significant TF-dependent procoagulant activity (TF PCA). In addition peptidoglycan, but not LTA or TSST-1, induced surface expression of the EC inflammation markers ICAM-1 and VCAM-1, which supported the adhesion of monocytes to these ECs. During the coculture of peptidoglycan-activated ECs and adherent monocytes, a marked additional increase of TF PCA was observed. Marginal increases in TF PCA were observed in cocultures of monocytes with LTA- or TSST-1-activated ECs. This study defines in particular staphylococcal peptidoglycan, previously known as a potent initiator of TF PCA in monocytes, as also being an activator of a coagulant response in human ECs that is further intensified by the presence of surface-bound monocytes.

    Topics: Bacterial Toxins; Blood Coagulation; Cell Adhesion; Coculture Techniques; Endothelial Cells; Enterotoxins; Gene Expression Profiling; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Monocytes; Peptidoglycan; RNA, Messenger; Staphylococcus aureus; Superantigens; Teichoic Acids; Thromboplastin; Vascular Cell Adhesion Molecule-1

2008
Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan.
    Infection and immunity, 2004, Volume: 72, Issue:7

    Lipoteichoic acid from Staphylococcus aureus was a potent inducer of procoagulant activity in isolated mononuclear cells but not in whole blood. In contrast, staphylococcal peptidoglycan showed equal levels of potency in isolated mononuclear cells and whole blood, suggesting that peptidoglycan is an important inducer of procoagulant activity in severe sepsis involving gram-positive bacteria.

    Topics: Blood; Blood Coagulation; Coagulants; Humans; Lipopolysaccharides; Monocytes; Peptidoglycan; Staphylococcus aureus; Teichoic Acids; Thromboplastin

2004